NHSLA Level 3 Compliance by 2012
TERMS OF REFERENCE
Management Board
1. Constitution
T
he board of directors has established a committee, known as the management board, (the committee) reporting to the board, in accordance with standing order 6 for the practice and procedure of the board of directors (annex 8 of the constitution).The committee shall have terms of reference and powers and be subject to such conditions, such as reporting back to the board, as the board shall decide and shall act in accordance with any legislation and regulation or direction issued by the regulator.
The committee shall be an executive committee of the board and has executive powers specifically delegated in these terms of reference.
2. Terms of Reference
a. Purpose
The role of the committee is to formulate recommendations on strategic matters for referral to the board of directors for approval. The committee will also monitor the effective and efficient finance, performance, quality and safety management of the trust.
b. Duties
The primary responsibility of the committee is to ensure the effective forward and current management of The Christie, to report key issues and provide advice to the board of directors.
• To formulate recommendations on strategic matters for the board of directors to decide.
• To advise the board of directors, audit committee and quality assurance committee of any unacceptable level of risk or lack of assurance in relation to strategic plans, operational performance or finance.
• To ensure delivery of the corporate plan.
• To commission, review and act upon specific pieces of work to address particular issues.
• To ensure that The Christie is in compliance with external assessment and accreditation bodies.
• To review and monitor corporate performance taking such action as is required to ensure delivery of financial and operational targets together with quality and safety of patient care and treatment.
• To oversee the development of service plans using revenue or capital funding and to agree these and/or to recommend action at board of directors level.
• To ensure understanding of the business of The Christie between clinical and corporate divisions and disease orientated groups and their chairs.
3. Membership The committee membership will include:
Chair – Chief Executive
Vice Chair – Deputy Chief Executive/Chief Operating Officer Executives – All executive directors
Divisional Representatives – all deputy chief operating officers
The chair of the committee shall be the chief executive or, in her
Risk management strategy and framework RM01 Version 01.4
Page 31 of 52
absence, one of the executive directors.
a. Quorum
Business will only be conducted if the meeting is quorate. The committee will be quorate with not less than three executive directors (or their appointed deputies) and five other members, including the Chair or Vice Chair, being present.
b. Attendance by Members
100% attendance is expected by the Chair or Vice Chair. Other Committee members will be required to attend a minimum of 80% of all meetings and be allowed to send a Deputy to two meetings per annum.
c. Attendance by Others
Other senior officers of the trust will be invited to present items or be present at discussions as the business of the committee dictates. In the absence of divisional or general managers a suitably senior divisional representative must attend and have authority to act.
4. Accountability and Reporting Arrangements
The proceedings of each meeting of the committee shall be reported to the next meeting of the board of directors. The chair shall draw to the attention of the board of directors any issues that require disclosure to the board or requires executive action.
Relationships with other committees
The committee receives information on clinical governance from the risk and quality governance committee.
The committee receives information from the divisional clinical boards.
This Committee will receive proposals from its sub-groups
• Informatics board
• Drugs management committee
• Research management committee
• Workforce and capital planning
• Caldecott committee
• Divisional boards
5. Frequency The committee shall meet twelve times per year. The chair may at any time convene additional meetings of the committee to consider
business that requires urgent attention.
6. Authority The committee is authorised by the board of directors to investigate any activity within its terms of reference. It may request and review reports and positive assurances from directors and managers and commission such work as is required to ensure optimal performance management of activity and finance.
The management board has delegated authority of the Board of Directors to approve business cases (both capital and revenue) up to a value of £500,000 (excluding VAT) per individual proposal.
The management board has delegated authority of the Board of Directors to award contracts up to a value of £500,000 (excluding VAT) subject to the contract being within the budget allocated.
7. Monitoring Effectiveness
The Committee will establish a work programme:
• That reflects its accountabilities and responsibilities
• To review and update annually these terms of reference, including
membership, recommending any changes to the board of directors
• To evaluate its own membership and performance on a regular basis
• The minutes of the Committee will be formally recorded and available on the Trust intranet
8. Dissemination of information
How will the committee ensure that all relevant actions, changes in practice or lessons for learning will be disseminated around the wider organisation.
e.g
Raised at Team Brief 9. Review The Committee will:
• Review and update annually within the first quarter of the year (Jan-March) as a minimum the terms of reference, including membership, recommending any changes to the board of directors 10. Administration The Committee shall be supported administratively by the executive
assistant to the deputy chief executive/chief operating officer, who will agree the agenda with the chair produce all necessary papers, attend meetings to take minutes, keep a record of matters arising and issues to be carried forward and generally provide support to the chair and members of the Committee.
Date Approved
Revised:
October 2008 February 2009 June 2009 September 2009 February 2012
Next Review Date February 2013
Risk management strategy and framework RM01 Version 01.4
Page 33 of 52 TERMS OF REFERENCE